SCHEMBL20065985

SCHEMBL20065985

B[C@H]1CCC[C@H](NC)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20065998 1.00
SCHEMBL20065981 1.00
SCHEMBL20065991 0.84
SCHEMBL20065977 0.84
SCHEMBL20065978 0.84
SCHEMBL20737115 0.81 ADH1B (0.41)
SCHEMBL9926873 0.81 ADH1B (0.41)
SCHEMBL220372 0.81 ADH1B (0.41)
SCHEMBL18856133 0.79 ALDH1A1 (0.36)
Ammonia Solution, Strong SCHEMBL7567537 0.78 ADH1B (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11834407-B2 Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists HEPTARES THERAPEUTICS LIMITED (GB) 2023-12-05 US disclosed
EP-3110810-B1 PYRAZOLE AMIDE DERIVATIVE TEIJIN PHARMA LTD (JP) 2018-05-02 EP disclosed
US-20180105491-A1 PHARMACEUTICAL COMPOUNDS NXERA PHARMA UK LIMITED (GB) 2018-04-19 US disclosed